| Bioactivity | Cepeginterferon alfa-2b is a pegylated interferon. And Cepeginterferon alfa-2b has PEG with molecular weight of 20 kDa as a pegylated base. Cepeginterferon alfa-2b can be used for research of various diseases, such as hepatitis C virus (HCV), polycythemia vera (PV) and essential thrombocythemia (ET)[1][2]. |
| Name | Cepeginterferon alfa-2b |
| CAS | 1192706-52-7 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Melikyan AL, et al. Cepeginterferon alfa-2b in the treatment of chronic myeloproliferative diseases. Ter Arkh. 2018 Aug 17;90(7):23-29. [2]. Znoyko OO, et al. Vozmozhnosti primeneniia tsepeginterferona al'fa-2b v sostave dvukh- (tsepeginterferon al'fa-2b i ribavirin) i trekhkomponentnoĭ (simeprevir, tsepeginterferon al'fa-2b i ribavirin) skhem protivovirusnoĭ terapii khronicheskogo gepatita S. Obzor klinicheskikh issledovaniĭ i opyta povsednevnoĭ klinicheskoĭ praktiki [Possibilities of using cepeginterferon alpha-2b in double (cepeginterferon alfa-2b and ribavirin) and triple (simeprevir, cepeginterferon alpha-2b, and ribavirin) antiviral therapy regimens for chronic hepatitis C. A review of clinical trials and experience of everyday clinical practice]. Ter Arkh. 2016;88(11):156-162. Russian. |